08/20/2014 - 6:55pm

Sales of sleep aids is still on the rise, driven primarily by private-label across both tablets and liquid formats.

08/20/2014 - 6:55pm

Bayer Diagnostics’ Contour Next portfolio has been performing exceptionally well lately, generating $12.4 million in front-end sales, up 226.6% for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.

08/20/2014 - 6:55pm

iHealth Lab recently launched its iHealth Align, one of the world’s smallest, FDA-approved mobile blood-glucose monitors.

08/20/2014 - 6:54pm

While diagnostics may be a $1.1 billion business at retail, the value inherent in that business, especially within the sale of blood-pressure monitors and blood-glucose meters, can be so much more.

08/20/2014 - 6:54pm

Pfizer successfully switched Nexium to over-the-counter in late May, and with that brought a $6 billion book of prescription business to antacid aisles, according to IMS Health data compiled over 2012.

08/20/2014 - 6:54pm

Thanks in part to the launch of Alka-Seltzer Fruit Chews in May of last year, the Alka-Seltzer brand has experienced a resurgence within the antacid tablet category.

08/20/2014 - 6:54pm

Reckitt Benckiser recently extended its Mucinex brand into the allergy set with the appropriately named Mucinex Allergy.

08/20/2014 - 6:54pm

With the recent switch of Chattem’s Nasacort 24HR, the first nasal corticosteroid to be sold OTC, Chattem launched a very unique marketing tool — an interactive shelf display that gives a whole new meaning to the term “shelf talker.”

08/20/2014 - 6:54pm

The allergy remedy business is growing, and not just because of new entries to the market like Chattem’s Nasacort 24HR, which to date has brought in more than $50 million to the category. Allergy seasons are lasting longer, and there are more people suffering from allergies.